In this episode of the DrBicuspid.com podcast, Kevin Henry speaks with Dr. Yoon Hong Cheol and Dr. Mike Miyasaki about the innovative biofluorescence technology developed by AIOBIO. They discuss the shift from reactive to preventive dentistry, the importance of building trust with patients through visual tools, and the commitment required for success in the dental field. The conversation also touches on the goals for 2026, focusing on expanding the use of biofluorescence technology in the United States.
Learn more at https://www.aiobio.com/home
All content for DrBicuspid is the property of DrBicuspid and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode of the DrBicuspid.com podcast, Kevin Henry speaks with Dr. Yoon Hong Cheol and Dr. Mike Miyasaki about the innovative biofluorescence technology developed by AIOBIO. They discuss the shift from reactive to preventive dentistry, the importance of building trust with patients through visual tools, and the commitment required for success in the dental field. The conversation also touches on the goals for 2026, focusing on expanding the use of biofluorescence technology in the United States.
Learn more at https://www.aiobio.com/home
Dr. Ben Alvarez on why this digital scanner impressed him
DrBicuspid
6 minutes 23 seconds
2 months ago
Dr. Ben Alvarez on why this digital scanner impressed him
In this episode, Dr. Ben Alvarez joins the show to discuss the Panda Scanner, which was evaluated by a group of Catapult clinicians, each with extensive experience using competitive scanners. Dr. Alvarez details what impressed him and why the product earned the Catapult Vote of Confidence — a recognition that underscores its role in making digital dentistry more attainable for everyday practices.
DrBicuspid
In this episode of the DrBicuspid.com podcast, Kevin Henry speaks with Dr. Yoon Hong Cheol and Dr. Mike Miyasaki about the innovative biofluorescence technology developed by AIOBIO. They discuss the shift from reactive to preventive dentistry, the importance of building trust with patients through visual tools, and the commitment required for success in the dental field. The conversation also touches on the goals for 2026, focusing on expanding the use of biofluorescence technology in the United States.
Learn more at https://www.aiobio.com/home
